Alliance Global Partners analyst James Molloy maintains Aquestive Therapeutics (NASDAQ:AQST) with a Buy and lowers the price target from $10 to $7.
September 27, 5:44 PM
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
September 27, 9:35 AM
Aquestive Therapeutics Inc (NASDAQ:AQST) announced positive topline results from the EPIPHAST 2 trial for its AQST-109 epinephrine sublingual film. The trial…
September 7, 6:48 AM
Gainers Biophytis S.A. (NASDAQ: BPTS) shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment.
Oppenheimer Initiates Coverage On Aquestive Therapeutics with Outperform Rating, Announces Price Target of $8.5
September 7, 5:08 AM
Oppenheimer analyst Francois Brisebois initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with a Outperform rating and announces Price Target of $8.5.
September 6, 6:34 PM
Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average volume over the last 100 days. The company's market cap stands at $22.7 million.
September 6, 11:23 AM
Citigroup cut the price target on FedEx Corporation (NYSE: FDX) from $270 to $225. Citigroup analyst Christian Wetherbee also downgraded the stock from Buy to Neutral. FedEx shares fell 3% to trade at $202.52 on Tuesday.
September 6, 6:08 AM
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aquestive Therapeutics (NASDAQ:AQST) with a Buy and lowers the price target from $6 to $5.